CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 462 enrolled
Drug / intervention
Indomethacin +4 moredrug
Likely dose
Indomethacin 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01543685
NCT01543685Phase 3Completed

A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin [Test] Capsules for the Treatment of Acute Postoperative Pain After Bunionectomy

Iroko Pharmaceuticals, LLC·interventional·Posted Mar 5, 2012·Updated Feb 4, 2014

In Brief

A Phase 3 clinical trial evaluating Indomethacin, Celecoxib, and 1 other intervention for Other Acute Postoperative Pain. Completed, enrolled 462 participants across 4 sites.

Detailed Summary

The purpose of this study is to determine whether Indomethacin \[Test\] Capsules are safe and effective for the treatment of postoperative bunionectomy pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 5, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJun 1, 2012
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 14.3 years ago

Interventions

Indomethacindrug

40 mg TID capsules

Indomethacindrug

40 mg BID capsules

Indomethacindrug

20 mg TID capsules

Celecoxibdrug

200 mg capsules

Placebodrug

Capsules